Tag Archives: abbv

Forget Google: 5 Top Stocks With Earnings Thursday

Tech titan Google (GOOGL) will make headlines with its quarterly earnings after the close on Thursday. But Google’s growth is sluggish and the stock is lackluster. Check out these five stocks with better performance than the search giant, including drugmaker AbbVie (ABBV) and coffee giant Starbucks (SBUX). Alexion, AbbVie Drug Earnings Alexion Pharmaceuticals (ALXN) is projected to see earnings decline by 13% to $1.33 a share when it reports its

AbbVie Upgraded On $7.8 Billion Imbruvica Potential

Big pharma AbbVie (ABBV) got an upgrade Monday from BMO Capital Markets, which warmed to the potential of its pending acquisition. Analyst Alex Arfaei upgraded AbbVie to outperform from market perform, saying that growing awareness of biosimilar competition for flagship drug Humira have driven down the stock to reasonable levels. At the same time, he was overcoming his initial skepticism toward AbbVie’s $21 billion payout to acquire Pharmacyclics

Top 5 IBD 50 Drug Stocks Thriving Via Acquisitions

The recent flurry of deal-making in the drug sector has put the spotlight on other top-rated drugmakers that have grown with the help of savvy mergers and acquisitions. In just the past week, AbbVie (ABBV) agreed to buy Pharmacyclics (PCYC) for $21 billion, beating out Johnson & Johnson (JNJ), and Mallinckrodt (MNK) announced a $2.3 billion deal to acquire privately held Ikaria. The latest IBD 50 includes five drugmakers that are growing quickly